Haverford Trust Co Buys Shares of 5,703 Danaher Corporation $DHR

Haverford Trust Co purchased a new position in Danaher Corporation (NYSE:DHR) in the 2nd quarter, HoldingsChannel.com reports. The firm purchased 5,703 shares of the conglomerate’s stock, valued at approximately $4,106,000.

Other large investors also recently modified their holdings of the company. Meeder Asset Management Inc. acquired a new stake in Danaher in the second quarter worth about $44,000. MidFirst Bank bought a new position in Danaher in the 2nd quarter valued at about $46,000. Bell Investment Advisors Inc acquired a new position in Danaher during the 2nd quarter valued at about $47,000. State of Wyoming bought a new stake in shares of Danaher during the 2nd quarter worth about $74,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the 4th quarter worth about $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Danaher Trading Up 1.6%

Shares of DHR opened at $219.42 on Friday. The business’s 50-day moving average price is $195.80 and its 200 day moving average price is $192.61. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $154.25 billion, a P/E ratio of 38.97, a P/E/G ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the company posted $0.77 earnings per share. Analysts expect that Danaher Corporation will post 8.53 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on DHR. Weiss Ratings raised shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. DZ Bank began coverage on Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Wells Fargo & Company decreased their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. Finally, Wall Street Zen cut Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.